======= CAPN10 =======
== Gene Information ==
* **Official Symbol**: CAPN10
* **Official Name**: calpain 10
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=11132|11132]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q9HC96|Q9HC96]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=CAPN10&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20CAPN10|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/605286|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: Calpains represent a ubiquitous, well-conserved family of calcium-dependent cysteine proteases. The calpain proteins are heterodimers consisting of an invariant small subunit and variable large subunits. The large catalytic subunit has four domains: domain I, the N-terminal regulatory domain that is processed upon calpain activation; domain II, the protease domain; domain III, a linker domain of unknown function; and domain IV, the calmodulin-like calcium-binding domain. This gene encodes a large subunit. It is an atypical calpain in that it lacks the calmodulin-like calcium-binding domain and instead has a divergent C-terminal domain. It is similar in organization to calpains 5 and 6. This gene is associated with type 2 or non-insulin-dependent diabetes mellitus (NIDDM), and is located within the NIDDM1 region. Multiple alternative transcript variants have been described for this gene. [provided by RefSeq, Sep 2010].
* **UniProt Summary**: N/A
|Calpain III|
|Peptidase C2|
|type B pancreatic cell apoptotic process|
|positive regulation of type B pancreatic cell apoptotic process|
|regulation of type B pancreatic cell apoptotic process|
|calcium-dependent cysteine-type endopeptidase activity|
|cellular component disassembly involved in execution phase of apoptosis|
|epithelial cell apoptotic process|
|positive regulation of epithelial cell apoptotic process|
|positive regulation of glucose import|
|positive regulation of glucose transmembrane transport|
|execution phase of apoptosis|
|regulation of glucose import|
|SNARE binding|
|actin cytoskeleton reorganization|
|positive regulation of insulin secretion|
|regulation of glucose transmembrane transport|
|cytoskeletal protein binding|
|regulation of epithelial cell apoptotic process|
|positive regulation of peptide hormone secretion|
|positive regulation of hormone secretion|
|cellular response to insulin stimulus|
|regulation of insulin secretion|
|positive regulation of transmembrane transport|
|positive regulation of intracellular transport|
|regulation of peptide hormone secretion|
|response to insulin|
|cellular response to peptide hormone stimulus|
|regulation of hormone secretion|
|positive regulation of protein secretion|
|positive regulation of peptide secretion|
|cellular response to peptide|
|regulation of intracellular transport|
|response to peptide hormone|
|cellular component disassembly|
|positive regulation of secretion by cell|
|positive regulation of protein transport|
|positive regulation of secretion|
|positive regulation of establishment of protein localization|
|regulation of protein secretion|
|response to peptide|
|actin cytoskeleton organization|
|regulation of peptide secretion|
|regulation of hormone levels|
|regulation of transmembrane transport|
|actin filament-based process|
|cellular response to organonitrogen compound|
|cellular response to hormone stimulus|
|positive regulation of apoptotic process|
|positive regulation of programmed cell death|
|cellular response to nitrogen compound|
|positive regulation of cell death|
|regulation of protein transport|
|regulation of peptide transport|
|regulation of establishment of protein localization|
|regulation of secretion by cell|
|regulation of secretion|
|response to hormone|
|regulation of cellular localization|
|apoptotic process|
|positive regulation of transport|
|response to organonitrogen compound|
|regulation of protein localization|
|programmed cell death|
|cellular response to oxygen-containing compound|
|response to nitrogen compound|
|cell death|
|cytoskeleton organization|
|cellular response to endogenous stimulus|
|mitochondrion|
|proteolysis|
|response to endogenous stimulus|
|regulation of apoptotic process|
|response to oxygen-containing compound|
|regulation of programmed cell death|
|regulation of cell death|
|positive regulation of cell communication|
|positive regulation of signaling|
|regulation of transport|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp288|HMS-I2 10μM R06 exp288]]|-1.72|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 11807
* **Expression level (log2 read counts)**: 5.24
{{:chemogenomics:nalm6 dist.png?nolink |}}